Genetic‐Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations
KK Lim, R Koleva‐Kolarova… - Journal of the …, 2024 - Am Heart Assoc
Background Genetic‐guided pharmacotherapy (PGx) is not recommended in clinical
guidelines for coronary artery disease (CAD). We aimed to examine the extent and quality of …
guidelines for coronary artery disease (CAD). We aimed to examine the extent and quality of …
The reversion of dna methylation at coronary heart disease risk loci in response to prevention therapy
Coronary heart disease (CHD) is preventable, but the methods for assessing risk and
monitoring response rely on imprecise lipid-based assessments. Recently, we have shown …
monitoring response rely on imprecise lipid-based assessments. Recently, we have shown …